Cadila Pharmaceuticals

Cadila Pharmaceuticals, established in 1951, is a privately held Indian pharmaceutical entity. Operating within the Pharmaceuticals and Healthcare sectors, the company has built a comprehensive, integrated business model. Its operations span the full spectrum of pharmaceutical manufacturing, encompassing Active Pharmaceutical Ingredients (APIs) and intermediates, finished formulations, Over-The-Counter (OTC) food supplements, and advanced Biotechnology Products. The company also produces pharmaceutical machinery, showcasing a diversified approach to the healthcare value chain.

With a significant operational footprint, Cadila Pharmaceuticals employs between 5,000 and 10,000 individuals across its 5 locations. This substantial workforce supports its extensive manufacturing capabilities and product development initiatives. The company's integrated operations are designed to ensure quality control from raw materials to finished goods. For insights into the people driving these efforts, you can Meet Cadila Pharmaceuticals' team. Their expertise underpins the company's ability to deliver a wide array of healthcare solutions.

Cadila Pharmaceuticals' product portfolio includes generic pharmaceuticals, APIs, and specialized healthcare products. The company's commitment to quality is evident in its manufacturing processes, which aim to meet stringent regulatory standards. While specific competitors are not detailed, its long history and integrated model position it as a key player in the Indian pharmaceutical market. The company's revenue stands at $2.4B, reflecting its considerable market presence and operational scale.